
äžç©ãªçå®ãé ãïŒè±åœæ¿åºã¯ãååã®å ±åæžã§COVIDã¯ã¯ãã³ãæ¥çš®ããåäŸã¯æ¥çš®ããŠããªãåäŸãã137åæ»äº¡ããããããšã蚌æãããåŸãæéåãã®å ±åæžã«åäŸã®æ»äº¡ãå«ããããšãæåŠ
å èšäºã¯ãã¡ããã/Click here to read the original article.
ããªã¹ãè±åœéŠçžãèŸä»»ãããããæ°æéåã«ãã¯ã¯ãã³æ¥çš®ã®ç¶æ³å¥ã®æ»äº¡æ°ã«é¢ããè¡æçãªå ±åæžãè±åœæ¿åºã«ãã£ãŠã²ã£ãããšçºè¡šãããã
ãã®å ±åæžã¯ãã¿ã€ãã³ã°çã«æ¿åºããã¿æ¶ãããšãæãã§ããããã¯ã¯ãã³æ¥çš®ãåããåã©ããã¡ã¯ãã¯ã¯ãã³æ¥çš®ãåããŠããªãåã©ããã¡ã«æ¯ã¹ãŠãäœããã®åå ã§æ»äº¡ãã確çã4423ïŒ ã45åãé«ããšããé©ãã¹ãçµæãæããã«ãªã£ãã®ã§ããã
ãããããã以äžã«è¡æçã ã£ãã®ã¯ãã¯ã¯ãã³ãæ¥çš®ããåã©ããã¡ã¯ãæ¥çš®ããŠããªãåã©ããã¡ã«æ¯ã¹ãŠ13,633ïŒ ãã€ãŸã137åãã³ãã19ã§æ»äº¡ãã確çãé«ããšãã蚌æã§ãã£ãããã®å ±åæžã¯ãäºé²æ¥çš®ã®å®å šæ§ãšæå¹æ§ã«æ·±å»ãªæžå¿µãæ±ããããã®ã§ãã£ãã
è±åœæ¿åºã¯ã2022幎9æã«ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡è æ°ã«é¢ããå ±åæžãå ¬è¡šãããšçŽæããŠããããåœå¢èª¿æ»ã§è±åœã®äººå£ããããŸã§èããããŠãããããå€ãããšã倿ãããããå ¬è¡šãå»¶æãããã
ãããã5ã«æåŸã®2023幎2æ21æ¥ã«ããããå ±åæžãçºè¡šãããããã®å ±åæžã§ã¯ã5æ³ã®ã¯ã¯ãã³æ¥çš®å ã®æ»äº¡æ å ±ãæäŸãããã¯ãã ã£ãããé©ãã¹ãããšã«ãè±åœæ¿åºã¯18æ³ä»¥äžã®äººã®ããŒã¿ã®ã¿ãæ²èŒããããšã«ããã®ã§ããã
ãã®æ±ºå®ã¯ãååã®å ±åæžã®10æ³ãã14æ³ã®ã¯ã¯ãã³æ¥çš®è ã®æ»äº¡çã«é¢ããè¡æçãªèª¿æ»çµæããå ±åæžã®å¯Ÿè±¡æéäžã«5æ³ã®åã©ããã¡ãã³ããã19ã¯ã¯ãã³ãæ¥çš®ããŠããããšãèãããšãçåãæ®ãã
å ±åæžã®æåºã5ã«æãé ããŠããã®ã«ãæ¿åºãã¯ã¯ãã³æ¥çš®ãåããåã©ããã¡ã®ããŒã¿ãé€å€ããããšã¯ãæ¿åºãäœãé ããŠããããšã匷ã瀺åããŠããã
ç¹ã«ãè±åœæ¿åºã2022幎8æãæ»äº¡è æ°ã22ïŒ å¢å ããããšãåããŠã5æ³ãã11æ³ã®åã©ããã¡ãžã®ã³ããã-19ã¯ã¯ãã³ã®å±éãäžæåæ¢ããäºå®ãšåããããšããã®äºå®ãæããã«ãªããŸãã
ãã®æŽé²ã¯ææ ®ãã¹ããã®ã§ãããè±åœæ¿åºã®éææ§ãšå ¬è¡è¡çãžã®ã³ãããã¡ã³ãã«æ·±å»ãªçåãæãããããã®ã§ãã
è±åœæ¿åºã¯äœãé ãããšããŠããã®ãããããŠãªãåœæ°ãèªåãã¡ã®å¥åº·ãåã©ããã¡ã®å¥åº·ã«ã€ããŠååãªæ å ±ãåŸãäžã§æ±ºæããããã«å¿ èŠãªãã¹ãŠã®æ å ±ãæäŸããªãã®ãïŒ
2023幎2æ21æ¥ãè±åœæ¿åºæ©é¢ã§ããOffice for National StatisticsïŒONSïŒã¯ã2022幎12æ31æ¥ãŸã§ã®ã€ã³ã°ã©ã³ãã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡è ããŒã¿ãçºè¡šããŸããã
ONSããã®æéåãã®ããŒã¿ã»ããã¯ããDeaths by Vaccination Status, England, 1 April 2021 to 31 December 2022ããšããã¿ã€ãã«ã§ãONSã®ãµã€ãã§ã¯ãã¡ãããã¢ã¯ã»ã¹ã§ããããŠã³ããŒããå¯èœã§ãã
ç§ãã¡ã¯çŸåšããã®æ°ããå ±åæžãåæäžã§ããããããŸã§ã®ãšããã2021幎4æ1æ¥ãã2022幎12æ31æ¥ãŸã§ã®Covid-19ã«ããæ»äº¡ã®10人ã«9人ã2022å¹Žå šäœã§ã¯Covid-19ã«ããæ»äº¡ã®92ïŒ ãããªãã«ïŒã¯ã¯ãã³æ¥çš®è ãå ããŠããããšã確èªãããŠããŸãã

ããããè±åœæ¿åºãããŒã¿ãæ²èŒããªãããšãéžæãããããåã©ãã®æ»äº¡çã«é¢ããŠã¯ã¯ãã³ã®å¹æã調ã¹ãããšãã§ããªãã
ä»åã®å ±åã¯5ã¶æé ãã§è¡ãããã®ã§ãåœå®¶çµ±èšå±ïŒONSïŒã«ã¯ã§ããã ãå€ãã®ããŒã¿ãå«ããæéããããŸããããå®éã«ã¯ãããŸã§çºè¡šãããäžã§æã詳现ãªå ±åã«ã¯ãªã£ãŠããŸããã
ååã7æ7æ¥ã«çºè¡šãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡çã«é¢ããå ±åæžã§ã¯ãæ²ããããšã«ãCOVIDã¯ã¯ãã³æ¥çš®å ã®æ»äº¡çããã¯ã¯ãã³æªæ¥çš®ã®10æ³ã®åã©ããã¡ãšæ¯ã¹ãŠæãããã»ã©é«ãããšãæããã«ãªããŸããã
以äžã®å³ã¯ã2022幎7æ7æ¥ã«çºè¡šãããå ±åæžã§ONSãæäŸããæ°å€ã«ããã2021幎1æ1æ¥ãã2022幎5æ31æ¥ãŸã§ã®ã€ã³ã°ã©ã³ãã«ããã10æ³ãã14æ³ã®åã©ãã®10äžäººå¹Žåœããã®ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡çã§ã - ã

Covid-19ã®æ»äº¡çã«ã€ããŠãONSã¯ã10æ³ãã14æ³ã®ã¯ã¯ãã³æªæ¥çš®å ã®æ»äº¡çã¯0.31ã«çããããšãæããã«ããããããã1åæ¥çš®ã®åã©ããã¡ã®æ»äº¡çã¯10äžäººå¹Žããã3.24人ã3åæ¥çš®ã®åã©ããã¡ã®æ»äº¡çã¯10äžäººå¹Žããã41.29人ãšãè¡æçãªæ°åã ã£ãã
ãããã®æ°åãããã³ãããæ¥çš®ããŠããªãåã©ãã¯ãã³ãããæ¥çš®ããåã©ãããããã³ãã19ã§æ»äº¡ãã確çãã¯ããã«äœãããšãæããã«ãªã£ãã
ãã¡ã€ã¶ãŒã®ã¯ã¯ãã³å¹æèšç®åŒã«åºã¥ãããã®ããŒã¿ãããã³ããã-19泚å°ã¯å°å ã®æ»äº¡ã«å¯ŸããŠè² ã®å¹æãããããšã蚌æããã2021幎1æãã2022幎5æãŸã§ã®å®è³ªçãªå¹æã¯ä»¥äžã®éãã§ããããšãæããã«ãªã£ã-ã

ã³ããã19ã®æ³šå°ã¯ãäžéšæ¥çš®ã®åã©ãã§ã¯ãã€ãã¹966.67ïŒ ã3åæ¥çš®ã®åã©ãã§ã¯ãã€ãã¹13,633.33ïŒ ãšãæ»äº¡ã«å¯ŸããçŸå®ã®ãã€ãã¹å¹æã蚌æãããã®ã§ããã
ããã¯ããã¡ã€ã¶ãŒã䞻匵ããæ»äº¡ã«å¯Ÿããæå¹ç95ïŒ ã«ã¯å°åºåã°ãªããã®ã§ãããã
ã€ãŸããéšåæ¥çš®å ã¯éæ¥çš®å ã«æ¯ã¹ãŠ11å/966.67ïŒ ã3åæ¥çš®å ã¯137.3å/13,633.33ïŒ ãã³ããã19ã§æ»äº¡ããå¯èœæ§ãé«ããšããããšã§ãã
ãããŠæ®å¿µãªãããã³ãã19以å€ã®æ»äº¡ã«é¢ããŠã¯ãã»ãšãã©æ¹åãèŠãããŸããã§ããã
å šæ»å æ»äº¡çã¯ãã¯ã¯ãã³æªæ¥çš®å ã§ã¯10äžäººå¹Žåœãã6.39ã«çžåœããäžéšæ¥çš®å ã§ã¯6.48ãšããããŸã§ã§ãããã«é«ãã£ãã
ãããããã®æ»äº¡çã¯æ³šå°ãæã€ãã³ã«æªåããŠãã£ããå šæ»å æ»äº¡çã¯ã2åæ¥çš®ã®åã©ãã§97.28ã3åæ¥çš®ã®åã©ãã§ã¯10äžäººå¹Žåœãã289.02ãšããè¡æçãªæ°åã«ãªã£ãã
ã€ãŸããè±åœæ¿åºã®å ¬åŒããŒã¿ã«ãããšã2皮混åã¯ã¯ãã³ãæ¥çš®ããåã©ããã¡ã¯ãæªæ¥çš®ã®åã©ããã¡ã«æ¯ã¹ãŠ1422ïŒ /15.22åãããããåå ã§æ»äº¡ãã確çãé«ãã£ãã®ã§ããäžæ¹ã3皮混åã¯ã¯ãã³ãæ¥çš®ããåã©ããã¡ã¯ãæªæ¥çš®ã®åã©ããã¡ã«æ¯ã¹ãŠ4423% / 45.23åãäœããã®åå ã§æ»äº¡ããå¯èœæ§ãé«ãããšãããã£ãã
2023幎ã«ãªãã2022幎7æã®å ±åæžãçºè¡šãããã»ãã®æ°ã¶æåã«ã5æ³ãã11æ³ã®åã©ããã¡ã«ã³ãã19ã®æ³šå°ãæäŸãããŸããã
ãããã9æã«çºè¡šãããã¯ãã®æ°å ±åæžã®å ¬éã¯5ã«æé ãã2023幎2æ21æ¥ã«ããããå ¬éãããã
ããããæ¿åºã¯ãªããããã¹ãŠã®åã©ããã¡ãå ¬è¡šããŒã¿ããé€å€ããããšã«ããã
ããã«ã¯çåãæ®ããäœãé ãããšããŠããã®ã ãããïŒ
ååã®å ±åæžã®æ°åãã·ã§ããã³ã°ãªãã®ã§ãã£ãããšã¯æããã§ãã
äžèšã®çç±ãšãæ»äº¡è æ°ã22ïŒ å¢å ããããšãåããŠãæ¿åºã9æã«5æ³ãã11æ³ãŸã§ã®ã¯ã¯ãã³å±éããäžæåæ¢ãããããšããå ±åæžãããã¹ãŠã®åã©ããé€å€ããããšã«æ±ºããçç±ã ãããïŒ
æ å ±ãšéææ§ã®æ¬ åŠã¯æ·±ãæžå¿µãããå ¬è¡è¡çãšå®å šã«å¯Ÿããæ¿åºã®åãçµã¿ã«æ·±å»ãªçåãæããããŠããã
ä»ã«äœãé ããŠããã®ã ãããïŒ
è±åœå¥åº·å®å šå±ãšããŠç¥ãããè±åœæ¿åºæ©é¢ã¯ã2022幎9æã«å¥åº·ãª5æ³ãã11æ³ã®åã©ããã¡ã«ã³ãã19ã¯ã¯ãã³ãæäŸããªãããšãçºè¡šããŸããã
ãã®æ±ºå®ã¯ãåœå®¶çµ±èšå±ãšåŒã°ããå¥ã®è±åœæ¿åºæ©é¢ã®å ¬åŒããŒã¿ãããNHSã2022幎4æ4æ¥ã«5æ³ãã11æ³ã®åã©ããžã®ã¯ã¯ãã³æ¥çš®ãéå§ããŠä»¥æ¥ã5æ³ãã9æ³ã®åã©ãã®æ»äº¡æ°ãéå»2幎éãšæ¯ã¹ãŠ22ïŒ å¢å ããŠããããšãæããã«ãªã£ãããšãåãããã®ã§ãã
以äžã®ã°ã©ãã¯ã2020幎ã2021幎ã2022幎ã®14é±ç®ãã35é±ç®ãŸã§ã®5æ³ãã9æ³ã®åã©ãã®å šäœã®æ»äº¡è æ°ã瀺ããŠããŸãã

2022幎4æã«ãNHSã¯ããNHSã¯ããã«ã¹ãµãŒãã¹å²äžæå€§ãã€æãæåããã¯ã¯ãã³æ¥çš®æŽ»åãæ¬¡ã®æ®µéã«ç§»è¡ããããã仿¥ãã5æ³ãã11æ³ã®åã©ããã¡ãžã®ã¯ã¯ãã³æ¥çš®ãéå§ããããšè¿°ã¹ãŸããã
åæã«ãGPã§NHS COVID-19ã¯ã¯ãã³æ¥çš®ããã°ã©ã ã®å¯ãªãŒããŒã§ããDr Nikki Kananiã¯ã次ã®ããã«è¿°ã¹ãŠããŸããããã®ã¯ã¯ãã³ã¯å®å šã§å¹æçã§ããç§ã®10æ³ã®åšãä»é±æ¥çš®ããäºå®ã§ããããã¹ãŠã®èŠªãæ å ±ãèªã¿ãã§ããã ãæ©ãæ©äŒã«åäŸãäºé²æ¥çš®ã«äºçŽããããšãæ€èšããããšããå§ãããŸããã
NHSãšããããŒã»ã«ããå士ãã幌å ã®æ»äº¡ãå¢å ããUKHSAããå¶ç¶ã5æ³ãã11æ³ãžã®Covid-19泚å°ã®å¿ èŠæ§ãèªããªããªã£ãä»ããããã®äž»åŒµããŸã æ¯æããŠãããã©ããã¯åãããªãã
Covid-19ã¯ã¯ãã³æ¥çš®ã«é¢ããè±åœæ¿åºã®éææ§ãšæ å ±ã®æ¬ åŠã¯ãææ ®ãã¹ããã®ã§ãã
ã¯ã¯ãã³æ¥çš®ãåããåã©ãã¯ãã¯ã¯ãã³æªæ¥çš®ã®åã©ããããæ»äº¡ãªã¹ã¯ãã¯ããã«é«ããšããéå»ã®å ±åããããåœæ°ãèªåãèªåã®æãã人ã®å¥åº·ã«ã€ããŠååãªæ å ±ãåŸãäžã§æ±ºæããããã«å¿ èŠãªãã¹ãŠã®æ å ±ãæäŸããããšã極ããŠéèŠã§ãã
ã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æ»äº¡æ°ã«é¢ããææ°ã®å ±åæžããåã©ããé€å€ãããšããæ±ºå®ã¯ãè±åœæ¿åºã®å ¬è¡è¡çã«å¯Ÿããåãçµã¿ãšãåœæ°ã®å®å šãšå¹žçŠãåªå ãããææã«ã€ããŠãæ·±å»ãªçåãæãããããã®ã§ããã
ãã®3幎éã§ãç§ãã¡ã¯ãæ¿åºã«å¯ŸããŠéææ§ãšèª¬æè²¬ä»»ãæ±ããããšããããŸã§ä»¥äžã«éèŠã§ããããšãåŠã³ãŸãããç¹ã«ãç§ãã¡ã®åã©ããæãã人ã®åœãå±éºã«ãããããŠãããšãã¯ãªãããã§ãã
ç§ãã¡ã¯ãCovid-19ã¯ã¯ãã³æ¥çš®ã«é¢é£ãããã¹ãŠã®ããŒã¿ã®å ¬éãåŒãç¶ãæ±ããç§ãã¡ã®å¥åº·ã«ã€ããŠååãªæ å ±ãåŸãäžã§æ±ºæããããã«å¿ èŠãªæ å ±ãæäŸãããããæ¿åºã«èŠæ±ããŠãããªããã°ãªããªãã®ã§ãã